Hormone Replacement Therapy Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Hormone Replacement Therapy (HRT) Market to 2027 - Global Analysis and Forecasts By Product ( Estrogen Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy, Other Hormone Replacement Therapy ); Route Of Administration ( Oral, Parenteral, Transdermal ); Type of Disease ( Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, Others )

Report Code: TIPRE00003836 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Hormone replacement therapy is used to help balance of hormones in men and women. During menopause, hormonal therapy (HT) or menopausal hormone therapy (MHT), hormone replacement therapy (HRT) can help relieve sweating, hot flashes, and other symptoms of menopause. Hormone therapy has also been proved to prevent bone loss and reduce fracture in postmenopausal women. Systemic hormone therapy which comes in pill, skin patch, cream, gel, or spray form, is the most effective treatment for the relief of troublesome menopausal hot flashes and night sweats.

MARKET DYNAMICS
The hormone replacement therapy market is anticipated to grow in the forecast, owing to the factors such as growing prevalence of hormonal imbalance disorders, increasing geriatric population, technological advancement in the field of drug delivery systems, and increasing awareness amongst women patients. However, the high cost of these therapies, and increasing risk of adverse cardiovascular diseases hampers the growth of the market.

MARKET SCOPE
The "Global Hormone Replacement Therapy Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of Hormone replacement therapy market with detailed market segmentation by product, route of administration, type of disease and geography. The global Hormone replacement therapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Hormone replacement therapy market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Hormone replacement therapy market is segmented on the basis of product, route of administration, type of disease and geography. Based on product, the market is segmented as estrogen replacement therapy, human growth hormone (HGH) replacement therapy, thyroid replacement therapy, testosterone replacement therapy, other hormone replacement therapy. On the basis of route of administration, the global hormone replacement therapy market is segmented into oral, parenteral and transdermal. The type of disease segment is further segmented into menopause, hypothyroidism, male hypogonadism, growth hormone deficiency, others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Hormone replacement therapy market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Hormone replacement therapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Hormone replacement therapy market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Hormone replacement therapy market in these regions.

MARKET PLAYERS
The reports cover key developments in the Hormone replacement therapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Hormone replacement therapy market are anticipated to lucrative growth opportunities in the future with the rising demand for Hormone replacement therapy market in the global market. Below mentioned is the list of few companies engaged in the Hormone replacement therapy market.

The report also includes the profiles of key Hormone replacement therapy market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Pfizer Inc.
  • Abbott
  • Novo Nordisk A/S
  • Novartis
  • Merck KGaA
  • Bayer AG
  • Eli Lilly and Company
  • Mylan Laboratories
  • F. Hoffmann-La Roche Ltd
  • Genentech Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hormone Replacement Therapy (HRT) Market - By Product
1.3.2 Hormone Replacement Therapy (HRT) Market - By Route of Administration
1.3.3 Hormone Replacement Therapy (HRT) Market - By Type of Disease
1.3.4 Hormone Replacement Therapy (HRT) Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. HORMONE REPLACEMENT THERAPY (HRT) MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HORMONE REPLACEMENT THERAPY (HRT) MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HORMONE REPLACEMENT THERAPY (HRT) MARKET - GLOBAL MARKET ANALYSIS
6.1. HORMONE REPLACEMENT THERAPY (HRT) - GLOBAL MARKET OVERVIEW
6.2. HORMONE REPLACEMENT THERAPY (HRT) - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. HORMONE REPLACEMENT THERAPY (HRT) MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. ESTROGEN REPLACEMENT THERAPY
7.3.1. Overview
7.3.2. Estrogen Replacement Therapy Market Forecast and Analysis
7.4. HUMAN GROWTH HORMONE (HGH) REPLACEMENT THERAPY
7.4.1. Overview
7.4.2. Human Growth Hormone (HGH) Replacement Therapy Market Forecast and Analysis
7.5. THYROID REPLACEMENT THERAPY
7.5.1. Overview
7.5.2. Thyroid Replacement Therapy Market Forecast and Analysis
7.6. TESTOSTERONE REPLACEMENT THERAPY
7.6.1. Overview
7.6.2. Testosterone Replacement Therapy Market Forecast and Analysis
7.7. OTHER HORMONE REPLACEMENT THERAPY
7.7.1. Overview
7.7.2. Other Hormone Replacement Therapy Market Forecast and Analysis
8. HORMONE REPLACEMENT THERAPY (HRT) MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. PARENTERAL
8.4.1. Overview
8.4.2. Parenteral Market Forecast and Analysis
8.5. TRANSDERMAL
8.5.1. Overview
8.5.2. Transdermal Market Forecast and Analysis
9. HORMONE REPLACEMENT THERAPY (HRT) MARKET - REVENUE AND FORECASTS TO 2027 - TYPE OF DISEASE
9.1. OVERVIEW
9.2. TYPE OF DISEASE MARKET FORECASTS AND ANALYSIS
9.3. MENOPAUSE
9.3.1. Overview
9.3.2. Menopause Market Forecast and Analysis
9.4. HYPOTHYROIDISM
9.4.1. Overview
9.4.2. Hypothyroidism Market Forecast and Analysis
9.5. MALE HYPOGONADISM
9.5.1. Overview
9.5.2. Male Hypogonadism Market Forecast and Analysis
9.6. GROWTH HORMONE DEFICIENCY
9.6.1. Overview
9.6.2. Growth Hormone Deficiency Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. HORMONE REPLACEMENT THERAPY (HRT) MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Hormone Replacement Therapy (HRT) Market Overview
10.1.2 North America Hormone Replacement Therapy (HRT) Market Forecasts and Analysis
10.1.3 North America Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Product
10.1.4 North America Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Type of Disease
10.1.6 North America Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Countries
10.1.6.1 United States Hormone Replacement Therapy (HRT) Market
10.1.6.1.1 United States Hormone Replacement Therapy (HRT) Market by Product
10.1.6.1.2 United States Hormone Replacement Therapy (HRT) Market by Route of Administration
10.1.6.1.3 United States Hormone Replacement Therapy (HRT) Market by Type of Disease
10.1.6.2 Canada Hormone Replacement Therapy (HRT) Market
10.1.6.2.1 Canada Hormone Replacement Therapy (HRT) Market by Product
10.1.6.2.2 Canada Hormone Replacement Therapy (HRT) Market by Route of Administration
10.1.6.2.3 Canada Hormone Replacement Therapy (HRT) Market by Type of Disease
10.1.6.3 Mexico Hormone Replacement Therapy (HRT) Market
10.1.6.3.1 Mexico Hormone Replacement Therapy (HRT) Market by Product
10.1.6.3.2 Mexico Hormone Replacement Therapy (HRT) Market by Route of Administration
10.1.6.3.3 Mexico Hormone Replacement Therapy (HRT) Market by Type of Disease
10.2. EUROPE
10.2.1 Europe Hormone Replacement Therapy (HRT) Market Overview
10.2.2 Europe Hormone Replacement Therapy (HRT) Market Forecasts and Analysis
10.2.3 Europe Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Product
10.2.4 Europe Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Type of Disease
10.2.6 Europe Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Hormone Replacement Therapy (HRT) Market
10.2.6.1.1 Germany Hormone Replacement Therapy (HRT) Market by Product
10.2.6.1.2 Germany Hormone Replacement Therapy (HRT) Market by Route of Administration
10.2.6.1.3 Germany Hormone Replacement Therapy (HRT) Market by Type of Disease
10.2.6.2 France Hormone Replacement Therapy (HRT) Market
10.2.6.2.1 France Hormone Replacement Therapy (HRT) Market by Product
10.2.6.2.2 France Hormone Replacement Therapy (HRT) Market by Route of Administration
10.2.6.2.3 France Hormone Replacement Therapy (HRT) Market by Type of Disease
10.2.6.3 Italy Hormone Replacement Therapy (HRT) Market
10.2.6.3.1 Italy Hormone Replacement Therapy (HRT) Market by Product
10.2.6.3.2 Italy Hormone Replacement Therapy (HRT) Market by Route of Administration
10.2.6.3.3 Italy Hormone Replacement Therapy (HRT) Market by Type of Disease
10.2.6.4 Spain Hormone Replacement Therapy (HRT) Market
10.2.6.4.1 Spain Hormone Replacement Therapy (HRT) Market by Product
10.2.6.4.2 Spain Hormone Replacement Therapy (HRT) Market by Route of Administration
10.2.6.4.3 Spain Hormone Replacement Therapy (HRT) Market by Type of Disease
10.2.6.5 United Kingdom Hormone Replacement Therapy (HRT) Market
10.2.6.5.1 United Kingdom Hormone Replacement Therapy (HRT) Market by Product
10.2.6.5.2 United Kingdom Hormone Replacement Therapy (HRT) Market by Route of Administration
10.2.6.5.3 United Kingdom Hormone Replacement Therapy (HRT) Market by Type of Disease
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Hormone Replacement Therapy (HRT) Market Overview
10.3.2 Asia-Pacific Hormone Replacement Therapy (HRT) Market Forecasts and Analysis
10.3.3 Asia-Pacific Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Type of Disease
10.3.6 Asia-Pacific Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Hormone Replacement Therapy (HRT) Market
10.3.6.1.1 Australia Hormone Replacement Therapy (HRT) Market by Product
10.3.6.1.2 Australia Hormone Replacement Therapy (HRT) Market by Route of Administration
10.3.6.1.3 Australia Hormone Replacement Therapy (HRT) Market by Type of Disease
10.3.6.2 China Hormone Replacement Therapy (HRT) Market
10.3.6.2.1 China Hormone Replacement Therapy (HRT) Market by Product
10.3.6.2.2 China Hormone Replacement Therapy (HRT) Market by Route of Administration
10.3.6.2.3 China Hormone Replacement Therapy (HRT) Market by Type of Disease
10.3.6.3 India Hormone Replacement Therapy (HRT) Market
10.3.6.3.1 India Hormone Replacement Therapy (HRT) Market by Product
10.3.6.3.2 India Hormone Replacement Therapy (HRT) Market by Route of Administration
10.3.6.3.3 India Hormone Replacement Therapy (HRT) Market by Type of Disease
10.3.6.4 Japan Hormone Replacement Therapy (HRT) Market
10.3.6.4.1 Japan Hormone Replacement Therapy (HRT) Market by Product
10.3.6.4.2 Japan Hormone Replacement Therapy (HRT) Market by Route of Administration
10.3.6.4.3 Japan Hormone Replacement Therapy (HRT) Market by Type of Disease
10.3.6.5 South Korea Hormone Replacement Therapy (HRT) Market
10.3.6.5.1 South Korea Hormone Replacement Therapy (HRT) Market by Product
10.3.6.5.2 South Korea Hormone Replacement Therapy (HRT) Market by Route of Administration
10.3.6.5.3 South Korea Hormone Replacement Therapy (HRT) Market by Type of Disease
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Hormone Replacement Therapy (HRT) Market Overview
10.4.2 Middle East and Africa Hormone Replacement Therapy (HRT) Market Forecasts and Analysis
10.4.3 Middle East and Africa Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Type of Disease
10.4.6 Middle East and Africa Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Hormone Replacement Therapy (HRT) Market
10.4.6.1.1 South Africa Hormone Replacement Therapy (HRT) Market by Product
10.4.6.1.2 South Africa Hormone Replacement Therapy (HRT) Market by Route of Administration
10.4.6.1.3 South Africa Hormone Replacement Therapy (HRT) Market by Type of Disease
10.4.6.2 Saudi Arabia Hormone Replacement Therapy (HRT) Market
10.4.6.2.1 Saudi Arabia Hormone Replacement Therapy (HRT) Market by Product
10.4.6.2.2 Saudi Arabia Hormone Replacement Therapy (HRT) Market by Route of Administration
10.4.6.2.3 Saudi Arabia Hormone Replacement Therapy (HRT) Market by Type of Disease
10.4.6.3 U.A.E Hormone Replacement Therapy (HRT) Market
10.4.6.3.1 U.A.E Hormone Replacement Therapy (HRT) Market by Product
10.4.6.3.2 U.A.E Hormone Replacement Therapy (HRT) Market by Route of Administration
10.4.6.3.3 U.A.E Hormone Replacement Therapy (HRT) Market by Type of Disease
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Hormone Replacement Therapy (HRT) Market Overview
10.5.2 South and Central America Hormone Replacement Therapy (HRT) Market Forecasts and Analysis
10.5.3 South and Central America Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Product
10.5.4 South and Central America Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Type of Disease
10.5.6 South and Central America Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Hormone Replacement Therapy (HRT) Market
10.5.6.1.1 Brazil Hormone Replacement Therapy (HRT) Market by Product
10.5.6.1.2 Brazil Hormone Replacement Therapy (HRT) Market by Route of Administration
10.5.6.1.3 Brazil Hormone Replacement Therapy (HRT) Market by Type of Disease
10.5.6.2 Argentina Hormone Replacement Therapy (HRT) Market
10.5.6.2.1 Argentina Hormone Replacement Therapy (HRT) Market by Product
10.5.6.2.2 Argentina Hormone Replacement Therapy (HRT) Market by Route of Administration
10.5.6.2.3 Argentina Hormone Replacement Therapy (HRT) Market by Type of Disease
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. HORMONE REPLACEMENT THERAPY (HRT) MARKET, KEY COMPANY PROFILES
12.1. PFIZER INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ABBOTT
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NOVO NORDISK A/S
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. NOVARTIS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MERCK KGAA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BAYER AG
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ELI LILLY AND COMPANY
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MYLAN LABORATORIES
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. F. HOFFMANN-LA ROCHE LTD
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. GENENTECH INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer Inc.
2. Abbott
3. Novo Nordisk A/S
4. Novartis
5. Merck KGaA
6. Eli Lilly and Company
7. Mylan Laboratories
8. F. Hoffmann-La Roche Ltd
9. Genentech Inc.
10. Bayer AG
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book